Table 3

Clinical outcomes: propensity score-matched cohort

OutcomesEVT
(n=184)
No EVT
(n=184)
OR
(95% CI)
P values
Primary outcome
  mRS score 0–2 at 90 days, n (%)105 (57.1)60 (32.6)2.74 (1.79 to 4.19)<0.0001
Secondary outcomes
  mRS score 0–1 at 90 days, n (%)66 (35.9)40 (21.7)2.01 (1.26 to 3.19)0.003
  Mortality at 90 days, n (%)7 (3.8)12 (6.5)0.56 (0.21 to 1.47)0.34
Safety outcomes
  Intracranial hemorrhage within 72 hours, n (%)51 (27.7)55 (29.9)0.83 (0.53 to 1.31)0.48
  Symptomatic intracranial hemorrhage within 72 hours, n (%)7 (3.8)9 (4.9)0.72 (0.26 to 2.00)0.61
  • EVT, endovascular therapy; mRS, modified Rankin Scale.